Association Between Bariatric Surgery and Major Adverse Diabetes Outcomes in Patients With Diabetes and Obesity | Bariatric Surgery | JAMA Network Open | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.153.100.128. Please contact the publisher to request reinstatement.
1.
Hofsø  D, Jenssen  T, Hager  H, Røislien  J, Hjelmesaeth  J.  Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects.   Obes Surg. 2010;20(3):302-307. doi:10.1007/s11695-009-0022-5 PubMedGoogle ScholarCrossref
2.
Afshin  A, Forouzanfar  MH, Reitsma  MB,  et al; GBD 2015 Obesity Collaborators.  Health effects of overweight and obesity in 195 countries over 25 years.   N Engl J Med. 2017;377(1):13-27. doi:10.1056/NEJMoa1614362PubMedGoogle ScholarCrossref
3.
Fontaine  KR, Redden  DT, Wang  C, Westfall  AO, Allison  DB.  Years of life lost due to obesity.   JAMA. 2003;289(2):187-193. doi:10.1001/jama.289.2.187 PubMedGoogle ScholarCrossref
4.
Chang  S-H, Stoll  CRT, Song  J, Varela  JE, Eagon  CJ, Colditz  GA.  The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012.   JAMA Surg. 2014;149(3):275-287. doi:10.1001/jamasurg.2013.3654 PubMedGoogle ScholarCrossref
5.
Adams  TD, Gress  RE, Smith  SC,  et al.  Long-term mortality after gastric bypass surgery.   N Engl J Med. 2007;357(8):753-761. doi:10.1056/NEJMoa066603 PubMedGoogle ScholarCrossref
6.
Mingrone  G, Panunzi  S, De Gaetano  A,  et al.  Bariatric surgery versus conventional medical therapy for type 2 diabetes.   N Engl J Med. 2012;366(17):1577-1585. doi:10.1056/NEJMoa1200111 PubMedGoogle ScholarCrossref
7.
De Luca  M, Angrisani  L, Himpens  J,  et al.  Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).   Obes Surg. 2016;26(8):1659-1696. doi:10.1007/s11695-016-2271-4 PubMedGoogle ScholarCrossref
8.
Hemmingsen  B, Lund  SS, Gluud  C,  et al.  Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.   Cochrane Database Syst Rev. 2013;(11):CD008143. doi:10.1002/14651858.CD008143.pub3PubMedGoogle Scholar
9.
Moghissi  ES, Korytkowski  MT, DiNardo  M,  et al; American Association of Clinical Endocrinologists; American Diabetes Association.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.   Diabetes Care. 2009;32(6):1119-1131. doi:10.2337/dc09-9029 PubMedGoogle ScholarCrossref
10.
Simonson  DC, Halperin  F, Foster  K, Vernon  A, Goldfine  AB.  Clinical and patient-centered outcomes in obese patients with type 2 diabetes 3 years after randomization to Roux-en-Y gastric bypass surgery versus intensive lifestyle management: The SLIMM-T2D study.   Diabetes Care. 2018;41(4):670-679. doi:10.2337/dc17-0487 PubMedGoogle ScholarCrossref
11.
Schauer  PR, Bhatt  DL, Kirwan  JP,  et al; STAMPEDE Investigators.  Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes.   N Engl J Med. 2017;376(7):641-651. doi:10.1056/NEJMoa1600869 PubMedGoogle ScholarCrossref
12.
Mingrone  G, Panunzi  S, De Gaetano  A,  et al.  Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial.   Lancet. 2021;397(10271):293-304. doi:10.1016/S0140-6736(20)32649-0 PubMedGoogle ScholarCrossref
13.
Eliasson  B, Liakopoulos  V, Franzén  S,  et al.  Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study.   Lancet Diabetes Endocrinol. 2015;3(11):847-854. doi:10.1016/S2213-8587(15)00334-4 PubMedGoogle ScholarCrossref
14.
Ramanan  B, Gupta  PK, Gupta  H, Fang  X, Forse  RA.  Development and validation of a bariatric surgery mortality risk calculator.   J Am Coll Surg. 2012;214(6):892-900. doi:10.1016/j.jamcollsurg.2012.02.011 PubMedGoogle ScholarCrossref
15.
Whiteford  HA, Degenhardt  L, Rehm  J,  et al.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.   Lancet. 2013;382(9904):1575-1586. doi:10.1016/S0140-6736(13)61611-6 PubMedGoogle ScholarCrossref
16.
Doumouras  AG, Saleh  F, Gmora  S, Anvari  M, Hong  D.  Regional variations in the public delivery of bariatric surgery: an evaluation of the Center of Excellence Model.   Ann Surg. 2016;263(2):306-311. doi:10.1097/SLA.0000000000001129 PubMedGoogle ScholarCrossref
17.
Doumouras  AG, Saleh  F, Anvari  S, Gmora  S, Anvari  M, Hong  D.  Mastery in bariatric surgery: the long-term surgeon learning curve of Roux-en-Y gastric bypass.   Ann Surg. 2018;267(3):489-494. doi:10.1097/SLA.0000000000002180PubMedGoogle ScholarCrossref
18.
Doumouras  AG, Saleh  F, Hong  D.  30-Day readmission after bariatric surgery in a publicly funded regionalized center of excellence system.   Surg Endosc. 2016;30(5):2066-2072. doi:10.1007/s00464-015-4455-8 PubMedGoogle ScholarCrossref
19.
Lipscombe  LL, Hwee  J, Webster  L, Shah  BR, Booth  GL, Tu  K.  Identifying diabetes cases from administrative data: a population-based validation study.   BMC Health Serv Res. 2018;18(1):316. doi:10.1186/s12913-018-3148-0 PubMedGoogle ScholarCrossref
20.
Austin  PC.  An introduction to propensity score methods for reducing the effects of confounding in observational studies.   Multivariate Behav Res. 2011;46(3):399-424. doi:10.1080/00273171.2011.568786 PubMedGoogle ScholarCrossref
21.
Austin  PC.  Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.   Stat Med. 2009;28(25):3083-3107. doi:10.1002/sim.3697 PubMedGoogle ScholarCrossref
22.
Rubino  F, Nathan  DM, Eckel  RH,  et al; Delegates of the 2nd Diabetes Surgery Summit.  Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations.   Diabetes Care. 2016;39(6):861-877. doi:10.2337/dc16-0236 PubMedGoogle ScholarCrossref
23.
Aminian  A, Zajichek  A, Arterburn  DE,  et al.  Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity.   JAMA. 2019;13:1271-1282. doi:10.1001/jama.2019.14231 PubMedGoogle ScholarCrossref
24.
Zhuang  XD, He  X, Yang  DY,  et al.  Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials.   Cardiovasc Diabetol. 2018;17(1):79. doi:10.1186/s12933-018-0722-zPubMedGoogle ScholarCrossref
25.
O’Brien  MJ, Karam  SL, Wallia  A,  et al.  Association of second-line antidiabetic medications with cardiovascular events among insured adults with type 2 diabetes.   JAMA Netw Open. 2018;1(8):e186125. doi:10.1001/jamanetworkopen.2018.6125 PubMedGoogle Scholar
26.
Doumouras  AG, Lee  Y, Babe  G,  et al.  The hidden cost of an extensive preoperative work-up: predictors of attrition after referral for bariatric surgery in a universal healthcare system.   Surg Endosc. 2020;34(2):988-995. doi:10.1007/s00464-019-06894-9 PubMedGoogle ScholarCrossref
27.
Goldberg  I, Yang  J, Nie  L,  et al.  Safety of bariatric surgery in patients older than 65 years.   Surg Obes Relat Dis. 2019;15(8):1380-1387. doi:10.1016/j.soard.2019.05.016 PubMedGoogle ScholarCrossref
28.
Doumouras  AG, Hong  D, Lee  Y, Tarride  J-E, Paterson  JM, Anvari  M.  Association between bariatric surgery and all-cause mortality: a population-based matched cohort study in a universal health care system.   Ann Intern Med. 2020;173(9):694-703. doi:10.7326/M19-3925 PubMedGoogle ScholarCrossref
29.
Scozzari  G, Passera  R, Benvenga  R, Toppino  M, Morino  M.  Age as a long-term prognostic factor in bariatric surgery.   Ann Surg. 2012;256(5):724-728. doi:10.1097/SLA.0b013e3182734113 PubMedGoogle ScholarCrossref
30.
Ghouse  J, Isaksen  JL, Skov  MW,  et al.  Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.   Diabetes Obes Metab. 2020;22(2):231-242. doi:10.1111/dom.13891 PubMedGoogle ScholarCrossref
31.
Simpson  SH, Eurich  DT, Majumdar  SR,  et al.  A meta-analysis of the association between adherence to drug therapy and mortality.   BMJ. 2006;333(7557):15. doi:10.1136/bmj.38875.675486.55 PubMedGoogle ScholarCrossref
32.
Doumouras  AG, Saleh  F, Sharma  AM,  et al.  Geographic and socioeconomic factors affecting delivery of bariatric surgery across high- and low-utilization healthcare systems.   Br J Surg. 2017;104(7):891-897. doi:10.1002/bjs.10517PubMedGoogle ScholarCrossref
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    Original Investigation
    Surgery
    April 26, 2021

    Association Between Bariatric Surgery and Major Adverse Diabetes Outcomes in Patients With Diabetes and Obesity

    Author Affiliations
    • 1Division of General Surgery, McMaster University, Hamilton, Canada
    • 2ICES, Toronto, Canada
    • 3Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Canada
    • 4Population Health Research Institute, Hamilton, Canada
    • 5Department of Medicine, McMaster University, Hamilton, Canada
    • 6Department of Medicine, University of Toronto, Toronto, Canada
    • 7Sunnybrook Research Institute, Toronto, Canada
    • 8Programs for Assessment of Technology in Health Research Institute, St Joseph’s Healthcare, McMaster University, Hamilton, Canada
    • 9Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University, Hamilton, Canada
    JAMA Netw Open. 2021;4(4):e216820. doi:10.1001/jamanetworkopen.2021.6820
    Key Points

    Question  Is there an association between bariatric surgery and all-cause mortality in patients with type 2 diabetes and severe obesity?

    Findings  In this cohort study that included 6910 patients with type 2 diabetes and severe obesity, there was a 47% decrease in all-cause mortality, a 68% decrease in cardiovascular mortality, and a 34% decrease in composite cardiac events associated with bariatric surgery compared with a nonsurgical control group after 4.6 years of follow-up. Patients who underwent surgery also had a 42% decrease in nonfatal renal events.

    Meaning  These findings suggest that bariatric surgery was associated with substantially lower all-cause mortality as well as nonfatal diabetic events in patients with type 2 diabetes.

    Abstract

    Importance  There are high-quality randomized clinical trial data demonstrating the effect of bariatric surgery on type 2 diabetes remission, but these studies are not powered to study mortality in this patient group. Large observational studies are warranted to study the association of bariatric surgery with mortality in patients with type 2 diabetes.

    Objective  To determine the association between bariatric surgery and all-cause mortality among patients with type 2 diabetes and severe obesity.

    Design, Setting, and Participants  This retrospective, population-based matched cohort study included patients with type 2 diabetes and body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) 35 or greater who underwent bariatric surgery from January 2010 to December 2016 in Ontario, Canada. Multiple linked administrative databases were used to define confounders, including age, baseline BMI, sex, comorbidities, duration of diabetes diagnosis, health care utilization, socioeconomic status, smoking status, substance abuse, cancer screening, and psychiatric history. Potential controls were identified from a primary care electronic medical record database. Data were analyzed in 2020.

    Exposure  Bariatric surgery (gastric bypass and sleeve gastrectomy) and nonsurgical management of obesity provided by the primary care physician.

    Main Outcomes and Measures  The primary outcome was all-cause mortality. Secondary outcomes were cause-specific mortality and nonfatal morbidities. Groups were compared through a multivariable Cox proportional Hazards model.

    Results  A total of 6910 patients (mean [SD] age at baseline, 52.04 [9.45] years; 4950 [71.6%] women) were included, with 3455 patients who underwent bariatric surgery and 3455 match controls and a median (interquartile range) follow-up time of 4.6 (3.22-6.35) years. In the surgery group, 83 patients (2.4%) died, compared with 178 individuals (5.2%) in the control group (hazard ratio [HR] 0.53 [95% CI, 0.41-0.69]; P < .001). Bariatric surgery was associated with a 68% lower cardiovascular mortality (HR, 0.32 [95% CI, 0.15-0.66]; P = .002) and a 34% lower rate of composite cardiac events (HR, 0.68 [95% CI, 0.55-0.85]; P < .001). Risk of nonfatal renal events was also 42% lower in the surgical group compared with the control group (HR, 0.58 [95% CI, 0.35-0.95], P = .03). Of the groups that had the highest absolute benefit associated with bariatric surgery, men had an absolute risk reduction (ARR) of 3.7% (95% CI, 1.7%-5.7%), individuals with more than 15 years of diabetes had an ARR of 4.3% (95% CI, 0.8%-7.8%), and individuals aged 55 years or older had an ARR of 4.7% (95% CI, 3.0%-6.4%).

    Conclusions and Relevance  These findings suggest that bariatric surgery was associated with reduced all-cause mortality and diabetes-specific cardiac and renal outcomes in patients with type 2 diabetes and severe obesity.

    ×